Search

Your search keyword '"Generic single-tablet regimen"' showing total 2 results
Start Over Descriptor "Generic single-tablet regimen"
2 results on '"Generic single-tablet regimen"'

1. Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Thai adults

Author

Anchalee Avihingsanon, Wirach Maek-a-nantawat, Sivaporn Gatechompol, Vorapot Sapsirisavat, Wanida Thiansanguankul, Jiratchaya Sophonphan, Narujakorn Thammajaruk, Sasiwimol Ubolyam, David M. Burger, and Kiat Ruxrungtham

Subjects
Generic single-tablet regimen, Tenofovir/lamivudine/efavirenz, HIV-infected adults, Resource-limited settings, Infectious and parasitic diseases, RC109-216
Abstract

Objective: To assess the efficacy and safety of a new single-tablet regimen (STR) of tenofovir disoproxil fumarate (TDF) 300 mg, lamivudine (3TC) 300 mg, and efavirenz (EFV) 600 mg in HIV-infected Thai patients. Methods: This was a prospective study performed for 144 weeks among 51 treatment-naïve patients and 49 experienced patients on separate tablets of TDF, 3TC, and EFV with HIV RNA

Published
2017
Full Text
View/download PDF

2. Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naive and experienced HIV-1-infected Thai adults

Author

Sasiwimol Ubolyam, Wanida Thiansanguankul, Anchalee Avihingsanon, Sivaporn Gatechompol, David M. Burger, Wirach Maek-a-nantawat, Jiratchaya Sophonphan, Kiat Ruxrungtham, Vorapot Sapsirisavat, and Narujakorn Thammajaruk

Subjects
Cyclopropanes, Male, 0301 basic medicine, Human immunodeficiency virus (HIV), HIV Infections, Pharmacology, medicine.disease_cause, chemistry.chemical_compound, 0302 clinical medicine, Generic single-tablet regimen, Antiretroviral Therapy, Highly Active, Antiretroviral naive, Medicine, Prospective Studies, 030212 general & internal medicine, Prospective cohort study, Lamivudine, General Medicine, Middle Aged, Thailand, Infectious Diseases, Alkynes, Female, Tenofovir/lamivudine/efavirenz, Tablets, medicine.drug, Adult, Microbiology (medical), medicine.medical_specialty, Efavirenz, Tenofovir, Anti-HIV Agents, HIV-infected adults, lcsh:Infectious and parasitic diseases, 03 medical and health sciences, Internal medicine, Humans, lcsh:RC109-216, business.industry, Adenine, Resource-limited settings, 030112 virology, Benzoxazines, CD4 Lymphocyte Count, Regimen, lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], chemistry, HIV-1, Once daily, business
Abstract

Contains fulltext : 177008.pdf (Publisher’s version ) (Open Access) OBJECTIVE: To assess the efficacy and safety of a new single-tablet regimen (STR) of tenofovir disoproxil fumarate (TDF) 300mg, lamivudine (3TC) 300mg, and efavirenz (EFV) 600mg in HIV-infected Thai patients. METHODS: This was a prospective study performed for 144 weeks among 51 treatment-naive patients and 49 experienced patients on separate tablets of TDF, 3TC, and EFV with HIV RNA

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results